Search by Drug Name or NDC

    NDC 68382-0409-77 Haloperidol 2 mg/1 Details

    Haloperidol 2 mg/1

    Haloperidol is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is HALOPERIDOL.

    Product Information

    NDC 68382-0409
    Product ID 68382-409_7c91727c-f19f-4d12-bfd8-f610cc1d3782
    Associated GPIs
    GCN Sequence Number 003975
    GCN Sequence Number Description haloperidol TABLET 2 MG ORAL
    HIC3 H7O
    HIC3 Description ANTIPSYCHOTICS,DOPAMINE ANTAGONISTS,BUTYROPHENONES
    GCN 15533
    HICL Sequence Number 001662
    HICL Sequence Number Description HALOPERIDOL
    Brand/Generic Generic
    Proprietary Name Haloperidol
    Proprietary Name Suffix n/a
    Non-Proprietary Name Haloperidol
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 2
    Active Ingredient Units mg/1
    Substance Name HALOPERIDOL
    Labeler Name Zydus Pharmaceuticals USA Inc.
    Pharmaceutical Class Typical Antipsychotic [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077580
    Listing Certified Through 2024-12-31

    Package

    NDC 68382-0409-77 (68382040977)

    NDC Package Code 68382-409-77
    Billing NDC 68382040977
    Package 10 BLISTER PACK in 1 CARTON (68382-409-77) / 10 TABLET in 1 BLISTER PACK (68382-409-30)
    Marketing Start Date 2023-02-01
    NDC Exclude Flag N
    Pricing Information N/A